Connection
Nicholas Cost to Urinary Bladder Neoplasms
This is a "connection" page, showing publications Nicholas Cost has written about Urinary Bladder Neoplasms.
|
|
Connection Strength |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_left.gif) |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_right.gif) |
|
1.359 |
|
|
|
-
Hecht SL, Walker JP, Treece AL, Cost NG. Isolated Pure Malignant Rhabdoid Tumor (MRT) of the Bladder: Case Report and Lessons Learned. Urology. 2020 Mar; 137:164-167.
Score: 0.563
-
Saltzman AF, Cost NG. Current Treatment of Pediatric Bladder and Prostate Rhabdomyosarcoma. Curr Urol Rep. 2018 Feb 22; 19(1):11.
Score: 0.500
-
Rodrigues Pessoa R, Morrison JC, Konety B, Gershman B, Maroni P, Kukreja JB, Cost N, Flaig T, Kessler E, Sharma P, Kim SP. National trends in clinical and pathologic staging for upper tract urothelial carcinoma: Implications for neoadjuvant chemotherapy. Urol Oncol. 2021 12; 39(12):832.e9-832.e15.
Score: 0.155
-
Halstead NV, Cost NG, Hecht SL, Walker JP. Neurofibromatosis-1 and Rhabdomyosarcoma: An Unusual Recurrence. Urology. 2020 Mar; 137:168-172.
Score: 0.141